Navigation Links
Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
Date:9/22/2008

orium. "This will also allow Encorium to continue to focus on profitability improvements and our cost reduction plan to help us achieve profitability as soon as possible."

"Our therapeutic focus areas of cardiology and vaccines, particularly in Europe, continue to provide significant growth opportunities," commented Dr. David Ginsberg, the new Chief Executive Officer of Encorium. "We are announcing today awards of $6.2 million of new business contracts, primarily consisting of vaccine clinical trials with a major global biopharmaceutical company to be conducted in multiple European countries. We also intend to expand and focus our growth efforts in additional therapeutic areas as well.

"The cost-cutting initiatives announced today, which are designed to save approximately $1.0 million annually, demonstrate our focus on achieving profitability and positive cash flow. We believe we are repositioning the business to take advantage of the high-growth opportunities in the clinical research industry and will continue to review strategic alternatives for the Company as we strive to make Encorium successful."

About Encorium Group, Inc.

Encorium Group, Inc. is a global clinical research organization specializing in the design and management of complex clinical trials and Patient Registries for the pharmaceutical, biotechnology and medical device industries. The Company's mission is to provide its clients with high quality, full-service support for their biopharmaceutical and medical device development programs. Encorium offers therapeutic expertise, experienced team management and advanced technologies. The Company has drug and biologics development as well as clinical trial experience across a wide variety of therapeutic areas such as infectious diseases, cardiovascular, vaccines, oncology, diabetes endocrinology/metabolism, gene therapy, immunology, neurology, gastroenterology, dermatology, hepatology, women's health and respiratory medicine. En
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
2. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
3. Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
4. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
5. Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R)
6. NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
7. Sunshine Heart Announces IDE Approval To Begin C-Pulse U.S. Clinical Feasibility Trial
8. Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
9. Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia
10. Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
11. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Nov. 20 BD (Becton, Dick...the completion of its acquisition of HandyLab, Inc...ops and manufactures molecular diagnostic assays a... HandyLab announced an exclusive agreement for BD ...he HandyLab Jaguar(TM) platform, the first fully i...
(Date:11/19/2009)...19 Warner Chilcott plc (Nasdaq: W...y announced secondary offering of 20,000,000 of it...25 per share. The selling shareholders include fu...chant Banking, J.P. Morgan Partners (advised by CC...ain other institutional investors and members of t...
(Date:11/19/2009).... 19 In a series of new ...Heska Corporation (Nasdaq: HSKA ) ("Heska" or the...and improved website. The upgraded site is the re...gramming to align the site with the company,s new ...: http://www.newscom.com/cgi-bin/prnh/20000622/H...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Researchers report benefits of new standard treatment study for rare pediatric brain cancer 59211 1Researchers report benefits of new standard treatment study for rare pediatric brain cancer 59211 2Mediterranean diet associated with reduced risk of depression 10311 1Mediterranean diet associated with reduced risk of depression 10311 2Common herbicides and fibrates block nutrient sensing receptor found in gut and pancreas 10307 1Common herbicides and fibrates block nutrient sensing receptor found in gut and pancreas 10307 2
... time when Australian,scientists are fighting hard...nt, an Australian biotech company is leading the w...cell research. , Apollo CEO John Priest said the c... help stem cells to develop into specific,cell typ...cells are basic cells that are not fully developed...
...ewswire-USNewswire/ -- The,Christopher and Dana Re...ganization dedicated to finding cures and treatmen...s of people living,with paralysis, today expressed... the Stem Cell Research Enhancement Act, which wou...l research with the,support and oversight of the f...
Other Medicine Technology:Apollo's human proteins boost stem cell research 2The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 2The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 3
(Date:11/22/2009)... , NEW YORK (Nov. 22 2009) -- Physician-scientist...ed a molecular mechanism that may prove to be a po...ymphoma, a type of cancer that affects lymphocytes...sm, researchers have been able to powerfully suppr...odels. , Promising results have led to the desig...
(Date:11/22/2009)... , Man & Machine post...oard versus the competition , ...puter keyboard users interested in learning what a...ant to tune into “Really Cool Keyboard vs Wa... Tube. The film demonstrates how the premium, Re...
(Date:11/21/2009)... , , NEW YORK, Nov. 21 Mi...L, of New York City, recently filed suit, in Supre...2009. The complaint alleges that while Ms. Lopez u...("TEE") at ST. VINCENT,S HOSPITAL , doctors used ... The complaint alleges that several hours after be...
(Date:11/21/2009)... , Innovative medical app...09 conference , San Cleme...reg;, maker of breakthrough medical apparel, today...h are on display at Medica 2009, a leading interna... Dusseldorf, Germany. Medelita inaugurates its men...
(Date:11/20/2009)... , , Pioneering Neurologist Closer to Unde...ON, Nov. 20 Dr. Jeremy ...cal School and neurologist at the Massachusetts Ge..., presented his laboratory,s research on the new f...of the MINDlink Foundation. ,, Dr. Schmahmann i...
Breaking Medicine News(10 mins):Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...th Florida neuroscientist reports that the cutting...es with Parkinsons disease is compelling on severa... did their job of easing disease symptoms. Pa...tary Neural Stem Cells for Parkinsons Disease: To ...
...ram Zoo has barred the entry of visitors for a wee... . The zoo has reportedly lost its entire s... the Indian bison - and 12 blackbucks in the week ...g sanitized and visitors are being disallowed from...
...ws that timid and withdrawn men increase their cha...percent, as against their more gregarious peers ...ip Greenland of Northwestern University of Chica... The study included extensive and detailed examina...
...-Farber Cancer Institute have identified a long-so... brown fat , a type of adipose tissue that generat... A team headed by Bruce Spiegelman, PhD, sugg... The investigators said their next step is to rev ...
...h has suggested that use of the anti-malarial drug...tients with rheumatoid arthritis developing diabet...ly 8 percent of US adults, and its prevalence has ...heumatoid arthritis, theoretically may improve glu...
...nd that good health habits of a person can influen... The study, published in the journal Healt...ole model can actually help a spouse take up a hea...is more likely to follow suit, the study suggests....
Other Medicine News:Health News:Stem Cells Research in Parkinsons Disease 2Health News:Male Wallflowers-Watch Your Heart 2Health News:Scientists Identified Obesity Control Switch 2Health News:Anti-malarial Drug may Help Reduce Risk of Diabetes in Rheumatoid Arthritis Patients 2Health News:A Role Model Spouse can Pass on Good Health Habits 2
The Natural-Hip Family - Revision/Trauma CoCr Revision
Oti Alfa Acetabular liners
Max-Rom Acetabular Liners
Bigliani/Flatow The Complete Shoulder Solution
Medicine Products: